+91-9896446475, +91-7015304764 |
generalmediquips@gmail.com |
Specifications
Type | Biphasic Defibrillators |
Feature | Portable |
Application | ICU, Cardiovascular, Emergency |
Brand | Philips |
Power Source | Electric |
Usage | Pharma indusrty |
The Philips HeartStart XL Defibrillator/Monitor is designed to meet a wide variety of defibrillation and monitoring needs in one lightweight, easy-to-use device.
REPLACEMENT for HP Codemaster XL+ Defibrillator/Monitor (discontinued).
Re-Certified Philips Agilent HeartStart XL Defibrillators (Model M4735A) includes:
In-stock Special on the Philips HeartStart XL Defibrillator with Pacing function, Hard Paddles, all accessories and 1 year warranty for $1795.00, Quick Ship! The Philips HeartStart XL Defibrillator/Monitor is designed to meet a wide variety of defibrillation and monitoring needs in one lightweight, easy-to-use device. At just under 14 lbs., the Philips (formerly Agilent) HeartStart XL is easily transported throughout the hospital to the site where cardiac care is needed. A combination manual device with automated external defibrillator capabilities, HeartStart XL enables the first caregiver on the scene, whether an ALS or BLS clinician, to deliver potentially lifesaving defibrillation therapy.
Phillips Defibrillator CapabilitiesIn AED mode, voice prompts and text messages guide BLS users through the defibrillation process, while the HeartStart XL M4735A continuously monitors and displays the patient’s ECG. Upon the arrival of ALS personnel, HeartStart XL is easily switched from AED to manual defibrillator mode, allowing operators to access the unit’s advanced therapeutic features such as selectable energy (from 2 to 200 Joules), non-invasive pacing (optional), SpO2 (optional) and synchronized cardioversion. SMART Biphasic technology. Philips pioneered biphasic therapy in external defibrillators and today biphasic is the standard of care.
Philips uses a combination of high current to maximize effectiveness and lower energy doses to minimize side effects that are harmful to a fragile heart. Philips biphasic therapy has been rigorously studied and is backed by a substantial body of peer-reviewed, published data. It has been clinically proven to deliver high first shock efficacy for long downtime sudden cardiac arrest (SCA) patients, and effectively defibrillate across the full spectrum of patients. Philips Medical’ SMART Biphasic waveform has undergone clinical testing, demonstrating its effectiveness for cardioversion of atrial fibrillation.
Easy to use, True 1-2-3 operation makes defibrillation intuitive for all users.
AED mode—Voice and text prompts guide users through the defibrillation process. 150 Joules non-escalating, pre-set energy level.